SciELO - Scientific Electronic Library Online

 
vol.24 issue2Basic notions of heart rate variability and its clinical applicabilityAdaptation of bioassay to detect endothelium-derived relaxing factors from the canine atrial endocardium author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Brazilian Journal of Cardiovascular Surgery

Print version ISSN 0102-7638On-line version ISSN 1678-9741

Rev Bras Cir Cardiovasc vol.24 no.2 São José do Rio Preto Apr./June 2009

http://dx.doi.org/10.1590/S0102-76382009000200019 

REVIEW ARTICLE

 

Bicuspid aortic valve: theoretical and clinical aspects of concomitant ascending aorta replacement

 

 

Mauro Paes Leme de SáI; Eduardo Sergio BastosII; Henrique MuradIII

IPhD, Clinical and Research Fellowship at the Toronto University, Canadá; Adjunct Professor of the Surgery Department, Federal University of Rio de Janeiro
IIPhD, Associated Professor of the Surgery Department, Medical School of the Federal University of Rio de Janeiro
IIIPhD, Titular Professor of the Surgery Department, Medical School of the Federal University of Rio de Janeiro

Correspondence address

 

 


ABSTRACT

Bicuspid aortic valve (BAV) is associated with annuloaortic ectasia, dissection and ascending aortic aneurysm. The high incidence of this congenital malformation and aortic disease suggests a close correlation between the two phenomena. Abnormalities in different phases of cell migration of the neural crest might be responsible for the occurrence of abnormalities in the aortic valve, media layer of the ascending aorta and vessels of the aortic arch. Previous studies have shown that patients with normal BAV or slight dysfunction may present with dilation of the aortic root. The hemodynamic changes caused by BAV without stenosis or insufficiency seem to be an insufficient explanation for these findings. Several mechanisms have been proposed to explain the molecular and hystological aspects of this disease. We found a reduced fibrillin-1 content in both ascending aorta and pulmonary trunk as a possible cause. Histologically, the ascending aorta can present cystic medial necrosis and elastic fragmentation, similar to Marfan's disease. Some authors concluded that many patients, mainly those with aortic regurgitation, should have the aortic valve and the ascending aorta replaced at the same procedure, even if a mild dilatation (45 mm) is present in patients with BAV if life expectancy is anticipated to be greater than 10 years to prevent further aneurysms or ruptures.

Descriptors: Aortic valve. Aortic aneurysm, thoracic. Aortic valve insufficiency. Aorta/pathology.


 

 

INTRODUCTION

Frequently, we find differences of opinions about the ideal surgical treatment to be offered to patients with bicuspid aortic valve (BAV). A significant number of these patients present, in addition to aortic valve dysfunction, aortic diameter near the upper limit of normal, and others present root ectasia or ascending aortic aneurysm. In clinical practice, we have reoperated several patients who had undergone previous aortic valve replacement, in relatively short periods of time, who are guided to our Service with ascending aortic aneurysms and/or aortic root.

In the last decade, a reasonable number of articles in the English-language literature brought to the discussion the complexity of this disease, seen over the years as an isolated change of the aortic valve morphology and whose presence of associated aneurysms was believed to be only result from hemodynamic changes.

This review raises the embryological aspects of this malformation, discusses the molecular and histological findings related to the fragility of the aortic wall and presents the experience of several authors in the surgical treatment of carriers of the BAV.

 

EMBRYOLOGICAL ASPECTS OF THE BICUSPID AORTIC VALVE AND GREAT VESSELS

The bicuspid presentation of the aortic valve is the most common heart valve abnormality [1-4], however, its morphogenesis is still cause for investigation. Sans-Coma et al. [5] concluded in an animal model that all morphological variants are developed from three mesenchymal cushions: right, left and dorsal, after the normal trunk-conal septation.

According to the authors, the bicuspid presentation of the aortic valve is not a result of improper development of the trunk-conal islets, bad trunk-conal septation, agenesis of the valvar cushions or valve lesions acquired after normal valvulogenesis. The fusion of right and left cushions in the beginning of valvulogenesis seems to be the key factor in the formation of bicuspid aortic valve (BAV). Each aortic valve acquires its configuration before the end of its formation process, in addition to the existence of a wide spectrum of valvular phenotypes, ranging from the bicuspid to tricuspid condition, with intermediate stages.

The neural crest is responsible for the formation of cardiac and non-cardiac structures. The neural crest-derived ectomesenchyme, occupying the III, IV and VI pharyngeal arches, participates in the formation of the carotid arteries, the aortic arch and ductus arteriosus, respectively. The muscle-connective tissue of the tunica media of arteries from the aortic arch are derived from neural crest. Furthermore, the neural crest cells play an important role in the formation of the trunk-conal. Anomalies occurring in different stages of migration of neural crest cells could be responsible for isolated or combined defects of the aortic arch, ascending aorta and aortic valve [6-8].

 

ANATOMOPATHOLOGICAL ASPECTS OF THE ASCENDING AORTA

In 1844 the particular susceptibility of the bicuspid aortic valve (BAV) to pathological processes had already been found, but little attention was given to this observation. In 1858, Peacock reported that the BAV tended to become thickened and calcified, leading first to the stenosis and subsequently, the incompetence. Osler in 1886, emphasized the vulnerability of the BAV to infective endocarditis. Since then, the tendency to infectious processes by this malformation of the aortic valve was recognized [9].

Previous pathological studies [10-12] point to the BAV as the most common cause of aortic valve disease in patients under 70 years of age in North America. It is also associated with higher prevalence of aortic coarctation [13], aortic dissection [14], annuloaortic ectasia [4,15-17] and spontaneous dissection of the innominate, carotid and vertebral arteries [18].

The high incidence of patients with congenital malformation of the aortic valve and aortic disease suggests a correlation between the two phenomena [18-20]. Larson and Edwards [21] demonstrated in anatomical study that the risk of aortic dissection was 9 times higher in patientswith BAV and 18 times higher in patients with unicommisural aortic valve when compared to patients with normal aortic valve, considering the valve malformation as an independent risk factor for aortic dissection. This same study pointed to the fact that the degeneration of the tunica media of the aorta is not determined by the functional status of the aortic valve or systemic arterial hypertension.

The other disease that severely compromises the aortic media layer is the Marfan syndrome, whose ocular and skeletal manifestations were described by Antoine Marfan in 1896. Etter and Glover, in 1943, and, posteriorly, Bear pointed to the serious cardiovascular manifestations of this autosomal dominant syndrome [22]. Only more than 50 years after Marfan description, it was observed that the development and subsequent rupture of an ascending aortic aneurysm were the most complications to be treated to protect the patient's lives with this syndrome, with reduction in life expectancy to one third. Vascular complications result from the weakness of the connective tissue [23.24], due to the reduction of fibrillin-1 in vascular matrix.

The research on Marfan syndrome pointed to the fact that the affected gene product would be expressed in structures common to different organ systems, allowing the appearance of skeletal, ocular and cardiovascular abnormalities, in addition to microfibrillar system abnormalities [25.26]. The main cardiovascular complications include dilation of the aortic root, dilation or dissection of the ascending aorta. Heart failure can occur associated with mitral and tricuspid valve insufficiency in the infantile form of the disease, resulting from the loss of support of the fibrous skeleton of the heart [27-29]. So intriguing, the histological changes found in the aortic medial layer in patients with Marfan syndrome (fragmentation of elastic fibers, cystic medial necrosis or accumulation of mucopolysaccharides and disorganization in smooth muscle cells) are nonspecific and commonly described, with intensity close to those found in some patients with BAV and ascending aortic aneurysms.

McKusick [30] reported the association between bicuspid aortic valve and cystic medial necrosis or Erdheim cystic necrosis in the aorta. Holman [31] believed that the histological changes of the aortic wall were result from the turbulence and the impact of the high-speed flow, due to the presence of a morphologically changed valve. Posteriorly, other researchers have shown that these changes occurred in patients with BAV with normal function or with changes in minimal functions [4,32,33]. The same author [30] questioned the hemodynamic stress as a causative factor of histological changes, since these changes were also found in the segment of abdominal aorta, mesenteric arteries, subclavian artery and, curiously, in the pulmonary artery.

Pachulski et al. [4] showed the occurrence of dilation of the aortic root in patients with normal BAV or minimal stenosis, whose systolic gradient was lower than 25 mmHg. Hahn et al. [32] confirmed these findings and affirmed that the phenomenon occurs regardless of age. Keane et al. [33] pointed to the possibility that the aortic dilation results primarily from intrinsic disease of its vessel wall and suggests that aortic valve regurgitation can play a favoring role in the development of such process. However, this study shows an association between aortic root diameter and males, age and increase in body surface.

The histological findings of Marfan syndrome are nonspecific, and had been described by several authors in patients with BAV [30,34-37]. However, its intensity may be different, presenting itself with both mild changes found in young and healthy patients, as external changes, such as those described in patients with Marfan syndrome. However, we believe that it is a result of improper synthesis of the protein responsible for skeletal microfibrillar of the elastic tissue and fibrous skeleton of the heart - the fibrillin1 [38].

Although other proteins constituting the microfibrils associated with elastin, fibrillin-1 is the most intensely investigated between them because of its association with the aforementioned syndrome [39]. It is also known that this glycoprotein is the main component of the microfibrils structures of the extracellular matrix and also serves as a framework for deposition of elastin [40].

McKusick was also the first to describe the association between the BAV and cystic necrosis in the medial layer of pulmonary artery. Excepting this case reported by the aforementioned author, the possibility of involvement of the pulmonary artery in this congenital malformation, involving the aortic valve, the ascending aorta and pulmonary artery, had never been investigated. During the fulfillment of the study published by David et al. [41], we noted that five patients with BVA, who had undergone Ross operation, presented dilation of the pulmonary autograft. This fact, combined with knowledge of the common embryological origin of the aortic and pulmonary roots, led to the extension of that study to the molecular structure of the large vessels of the base, confirming the reduction of fibrillin-1 in the ascending aorta and pulmonary artery of patients with BVA compared to the patients with normal or impaired tricuspid aortic valve, in addition to the increase in activity of metalloproteinase 2, enzymes responsible for elastic matrix components degradation [38]. Even more intriguing was the finding on these changes had no relation with age and that there was no difference in the amount of collagen between the studied groups.

Schmid et al. [42], assessing apoptosis in smooth muscle cells of large vessels in patients with BAV, did not describe that the dilation of the pulmonary autograft was result of pathological or molecular processes intrinsic to the vessel walls. Similarly, Della Corte et al. [43] when studing only patients with aortic stenosis, concluded that the disarrangement of smooth muscle cells and apoptosis are secondary to the stress caused by flow. The presence of aortic stenosis and aneurysm seems to be related to reduction of collagen in the aorta of patients with BAV, confirming our findings.

Cotrufo et al. [44] analyzing the composition of the extracellular matrix in different sites of the ascending aorta, described reduction of collagen type I and III of patients with BAV with aortic dilation and aortic insufficiency in relation to the normal specimens obtained from donors for transplantation and patients with BAV with stenosis.

Despite the apparently conflicting studies, clinical experience suggests that the group of patients with BAV and ascending aortic aneurysm may be a heterogeneous group, consisting of patients with ectasia or true aneurysms of the aortic root or also others who presented relatively normal aortic sinuses, with ascending aortic aneurysms from the sinotubular junction. The different anatomical locations of these vascular complications may reflect different mechanisms, or also different intensity of the same phenotypic expressions, resulting in distinct therapeutic implications [45].

The evidence points to the fact that vascular complications may represent part of a more complex malformation. In such cases, the histological changes of the vessels would not primarily caused by changes of flow, but a result of profound structural changes [37.38] determined during embryo formation. It is believed that different mechanisms may be involved in the physiopathology of aortic disease and these can be influenced but not determined by the functional state of the valve.

 

CLINICAL IMPLICATIONS IN AORTIC VALVE AND ASCENDING AORTIC SURGERY

The molecular and histological changes in vessels of the base in patients with BAV, although of controversial etiology, were recognized as important criteria for defining the surgical treatment, as occurs in patients with Marfan syndrome. These changes, although similar, differ in the intensity of clinical and laboratory manifestations.

According to Yasuda et al. [46], the aortic valve replacement, either by stenosis or failure, did not prevent the progressive dilation of the proximal aorta, which differs from that observed in patients with tricuspid aortic valve. The authors also suggest that in patients with aortic insufficiency, the aortic dilation progresses more acutely than in valvular stenosis.

Russo et al. [47], when following-up more than a hundred patients who underwent aortic valve replacement, also reported higher incidence of sudden death and aortic dissection in a group of patients with BAV, increase in aortic diameter significantly higher in this same group, suggesting that prophylactic surgery for replacement of the ascending aorta concomitant with valve replacement should be performed, even in the presence of mild dilation of the ascending aorta.

Borger et al. [48] in a clinical retrospective study assessing the aortic complications in patients with BAV, concluded that patients with aortic BAV with aortic diameter exceeding 45 mm should undergo combined surgery, or that is, aortic valve replacement and replacement of the ascending aorta to avoid reinterventions due to vascular complications, either aneurysms and dissections of the ascending aorta.

Brown et al. [49], assessing patients who had undergone Ross operation, of which 48% were under 19 years old, concluded that dilation of the pulmonary autograft is not common after this procedure, with 82% of patients free of dilation in 10 years of follow-up. The authors also commented that the major cause of aortic insufficiency in children and young adults is the presence of BAV and that an increased aortic annulus may be related to the enlargement of the autografting, in addition to technical failures in its fulfillment.

Article published by Davies et al. [50] in 2007 on the natural history of aneurysms of the ascending aorta in patients with BAV showed, after a mean follow-up of 65.1 months, that the aortic stenosis represents a risk factor in patients with BAV and aortic aneurysm. Despite the higher growth rate of aneurysms in this subgroup, the incidence of rupture, dissection or death was similar to the group with tricuspid aortic valve. The authors defined as aneurysm the diameter of the ascending aorta exceeding 3.5 cm and reported that approximately half of patients with BAV did not present aortic stenosis, considering the onset of aortic dilation in patients with normofunctioning BAV. It was not identified the association of the development of aneurysms between the age of the patients. This low rate of complications of the ascending aorta may have been influenced by the mean follow-up period relatively short of only 65.1 months.

Russo et al. [47] observed incidence of complications in the aorta significantly higher in patients with BAV compared to the group of patients with tricuspid aortic valve (TAV). This difference was evident only after a period of 10 years of follow-up. Also in the study of Davies et al., intervention rate of 77.1% in the aorta in patients with BAV was described. This intervention rate may have influenced the called natural history of the disease.

Study published by Etz et al. [51], including 206 carriers of BAV undergone Bentall operation, revealed important data from the clinical point of view: the patients were relatively young, mean age of 53 ± 14 years, 84% male, who underwent surgery due to presentation of BAV with impaired or dilated of the aortic root. Of the total, 52% presented pure aortic insufficiency, 26%, double-aortic lesion, and only 12% presented pure aortic stenosis. The mean preoperative aortic diameter was 5.5 cm, ranging from 3 to 9 cm. The authors report that in cases of surgery due to aortic valve disease, associated with a diameter of the root or ascending aorta exceeding 4.0 cm and life expectancy exceeding 10 years, the option was to replace both the valve and aorta. In patients with normofunctioning BAV, the Bentall operation was performed when the aortic diameter was greater than or equal to 5.5 cm. These data confirm our impression that the most severe histological changes are found in young patients when they have aortic insufficiency associated with aneurysms or ascending aortic dissections [37].

Study published by Girdauskas et al. [52] showed greater need for reoperation after surgical treatment of ascending aortic dissection type A in patients non-carriers of Marfan syndrome, but who presented severe histological changes in the medial layer of the aorta, specially cystic medial necrosis, compared to the group with less severe histological changes.

Recent publication of Lad et al. [53] describes the echocardiographic, surgical and pathological findings of 29 patients with BAV and associated mitral insufficiency, who had undergone surgical treatment. The authors report the presence of large anterior leaflet of mitral valve with prolapse and aortic annulus dilated (over 30 mm) in 28/29 patients. The authors also describe that 19 presented aortic insufficiency and 11 ascending aortic or aortic root aneurysm. They concluded describing the embryological relationship between the anterior leaflet of the mitral valve, the intervalvar fibrous trigone, the aortic cusps and the fibrous portion of the left ventricle outflow tract.

Sievers, commenting on the study of Lad et al. [53], reports the interest of surgeons to better classify the BAV and disclosure important concepts. The author also adds that the association of BAV and mitral insufficiency, with the need for surgical treatment represents a continuous spectrum of changes of a specific entity, the BAV, associated with mitral and aortic weakness, fusion or prolapse of the aortic leaflets associated or not with aortic insufficiency, ascending aortic dilation associated or not with the dilation of the Valsalva sinus, misalignment of the non-coronary sinus in relation to the left ventricular outflow tract, dilation of intercommissural triangles, dilation of the anterior mitral and aortic annulus, increase of the anterior leaflet of the mitral valve with or without prolapse and mitral insufficiency, predominantly affecting males. The author concludes his comment stating that there is now consensus on the genetic character of the disease and that the tissue fragility seems to be determined by the impairment of the matrix and not a consequence of degeneration.

 

CONCLUSION

Patients with impaired bicuspid aortic valve, especially with aortic annulus exceeding 30 mm, should undergo concomitant ascending aortic replacement on the occasion of the aortic valve replacement. In young patients, even in the presence of mild dilation of the aorta (above 45 mm) mainly associated with aortic valve insufficiency, a more extensive procedure can be justified (Bentall), aiming to prevent vascular complications. According to the studies assessed, the mechanisms that result in changes of the aortic wall may differ functionally when the aortic valve presents itself with stenosis or insufficiency. Patients with bicuspid aortic valve who had undergone surgery should be more intensely monitored by echocardiography.

 

REFERENCES

1. Campbell M. Calcific aortic stenosis and congenital bicuspid aortic valves. Br Heart J. 1968;30(5):606-16.         [ Links ]

2. Fenoglio JJ Jr, McAllister HA Jr, DeCastro CM, Davia JE, Cheitlin MD. Congenital bicuspid aortic valve after age 20. Am J Cardiol. 1977;39(2):164-9.         [ Links ]

3. Roberts WC. Valvular, subvalvular and supravalvular aortic stenosis: morphologic features. Cardiovasc Clin. 1973;5(1):97-126.         [ Links ]

4. Pachulski RT, Weinberg AL, Chan KL. Aortic aneurysm in patients with functionally normal or minimally stenotic bicuspid aortic valve. Am J Cardiol. 1991;67(8):781-2.         [ Links ]

5. Sans-Coma V, Fernández B, Durán AC, Thiene G, Arqué JM, Muñoz-Chápuli R, et al. Fusion of valve cushions as a key factor in the formation of congenital bicuspid aortic valves in Syrian hamsters. Anat Rec. 1996;244(4):490-8.         [ Links ]

6. Kirby ML. Cardiac morphogenesis: recent research advances. Pediatr Res. 1987;21(3):219-24.         [ Links ]

7. Nishibatake M, Kirby ML, Van Mierop LH. Pathogenesis of persistent truncus arteriosus and dextroposed aorta in the chick embryo after neural crest ablation. Circulation. 1987;75(1):255-64.         [ Links ]

8. Kappetein AP, Gittenberger-de Groot AC, Zwinderman AH, Rohmer J, Poelmann RE, Huysmans HA. The neural crest as a possible pathogenetic factor in coarctation of the aorta and bicuspid aortic valve. J Thorac Cardiovasc Surg. 1991;102(6):830-6.         [ Links ]

9. Roberts WC. The congenitally bicuspid aortic valve. A study of 85 autopsy cases. Am J Cardiol. 1970;26(1):72-83.         [ Links ]

10. Peterson MD, Roach RM, Edwards JE. Types of aortic stenosis in surgically removed valves. Arch Pathol Lab Med. 1985;109(9):829-32.         [ Links ]

11. Passik CS, Ackermann DM, Pluth JR, Edwards WD. Temporal changes in the causes of aortic stenosis: a surgical pathologic study of 646 cases. Mayo Clin Proc. 1987;62(2):119-23.         [ Links ]

12. Stephan PJ, Henry AC 3rd, Hebeler RF Jr, Whiddon L, Roberts WC. Comparison of age, gender, number of aortic valve cusps, concomitant coronary artery bypass grafting, and magnitude of left ventricular-systemic arterial peak systolic gradient in adults having aortic valve replacement for isolated aortic valve stenosis. Am J Cardiol. 1997;79(2):166-72.         [ Links ]

13. Abbott ME. Coarctation of the aorta of the adult type. Am Heart J. 1928;3:381-421.         [ Links ]

14. Gore I. Dissecting aneurysms of the aorta in persons under forty years of age. AMA Arch Pathol. 1953;55(1):1-13.         [ Links ]

15. Hahn RT, Roman MJ, Mogtader AH, Devereux RB. Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves. J Am Coll Cardiol. 1992;19(2):283-8.         [ Links ]

16. Dietz HC, Sood S, McIntosh I. The phenotypic continuum associated with FBN1 mutations includes the Shprintzen-Goldberg syndrome. Am J Hum Genet. 1995;57:1214.         [ Links ]

17. Fukunaga S, Akashi H, Tayama K, Kawano H, Kosuga K, Aoyagi S. Aortic root replacement for annuloaortic ectasia in Shprintzen-Goldberg syndrome: a case report. J Heart Valve Dis. 1997;6(2):181-3.         [ Links ]

18. Schievink WI, Mokri MB. Familial aorto-cervicocephalic arterial dissections and congenitally bicuspid aortic valve. Stroke. 1995;26(10):1935-40.         [ Links ]

19. Lindsay J Jr. Coarctation of the aorta, bicuspid aortic valve and abnormal ascending aortic wall. Am J Cardiol. 1988;61(1):182-4.         [ Links ]

20. Braveman AC. Bicuspid aortic valve and associated aortic wall abnormalities. Curr Opin Cardiol. 1996;11(5):501-3.         [ Links ]

21. Larson EW, Edwards WD. Risk factors for aortic dissection: a necropsy study of 161 cases. Am J Cardiol. 1984;53(6):849-55.         [ Links ]

22. Gott VL, Greene PS, Alejo D, Cameron DE, Naftel DC, Miller DC, et al. Replacemente of the aortic root in patients with Marfan's syndrome. N Eng J Med. 1999;340(17):1307-13.         [ Links ]

23. Murdoch JL, Walker BA, Halpern BL, Kuzma JW, McKusick VA. Life expectancy and causes of death in the Marfan syndrome. N Eng J Med. 1972;286(15):804-8.         [ Links ]

24. Baumgartner W, Cameron DE, Redmond M. Operative management of Marfan syndrome: The John Hopkins experience. Ann Thorac Surg. 1999;67:1859-60.         [ Links ]

25. Milewicz DM, Pyeritz RE, Crawford ES, Byers PH. Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts. J Clin Invest. 1992;89(1):79-86.         [ Links ]

26. Pyeritz RE. The Marfan syndrome. In: Royce PM, Steinmann B, editors. Connective tissue and its heritable disorders: molecular, genetic and medical aspects. New York:Wiley-Liss;1993. p.437-68.         [ Links ]

27. Beighton P, de Paepe A, Danks D, Finidori G, Gedde-Dahl T, Goodman R, et al. International Nosology of Hereditable Disorders of Connective Tissue, Berlin, 1986. Am J Med Genet. 1988;29(3):581-94.         [ Links ]

28. Geva T, Sanders SP, Diogenes MS, Rockenmacher S, Van Praagh R. Two-dimensional and Doppler echocardiographic and pathologic characteristics of the infantile Marfan syndrome. Am J Cardiol. 1990;65(18):1230-7.         [ Links ]

29. Kielty CM, Davies SJ, Phillips JE, Jones CJ, Shuttleworth CA, Charles SJ. Marfan syndrome: fibrillin expression and microfibrillar abnormalities in a family with predominant ocular defects. J Med Genet. 1995;32(1):1-6.         [ Links ]

30. McKusick VA. Association of congenital bicuspid aortic valve and erdheim's cystic medial necrosis. Lancet. 1972;1(7758):1026-7.         [ Links ]

31. Holman E. The obscure physiology of poststenotic dilation; its relation to the development of aneurysms. J Thorac Surg. 1954;28(2):109-33.         [ Links ]

32. Hahn RT, Roman MJ, Mogtader AH, Devereux RB. Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves. J Am Coll Cardiol. 1992;19(2):283-8.         [ Links ]

33. Keane MG, Wiegers SE, Plappert T, Pochettino A, Bavaria JE, Sutton MG. Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions. Circulation. 2000;102(19 Suppl 3):III35-9.         [ Links ]

34. Perejda A, Abraham PA, Carnes WH. Marfan's syndrome: structural, biomechanical studies of the aortic media. J Lab Clin Med 1985;106(4): 376-83.         [ Links ]

35. Edwards WD. Congenital heart disease. In: Damjanov I, Linder J, eds. Anderson's pathology. 10th ed. St. Luis:Mosby Year Book;1996. p.1377.         [ Links ]

36. Fukunaga S, Akashi H, Tayama K, Kawano H, Kosuga K, Aoyagi S. Aortic root replacement for annuloaortic ectasia in Shprintzen-Goldberg syndrome: a case report. J Heart Valve Dis. 1997;6(2):181-3.         [ Links ]

37. Sá M, Moshkovitz Y, Butany J, David TE. Histologic abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aortic valve disease: clinical relevance to the Ross procedure. J Thorac Cardiovasc Surg. 1999;118(4):588-94.         [ Links ]

38. Fedak PW, de Sá MP, Verma S, Nili N, Kazemian P, Butany J, et al. Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. J Thorac Cardiovasc Surg. 2003;126(3):797-806.         [ Links ]

39. Schaefer GB, Godfrey M. Quantitation of fibrillin immunofluorescence in fibroblast cultures in the Marfan syndrome. Clin Genet. 1995;47(3):144-9.         [ Links ]

40. Cleary EG, Gibson MA. Elastin-associated microfibrils and microfibrillar proteins. Int Rev Connect Tissue Res. 1983;10:97-209.         [ Links ]

41. David TE, Onram A, Ivanov J, Armstrong S, de Sá MP, Sonnenberg B, et al. Dilation of the pulmonary autograft after the Ross procedure. J Thorac Cardiovasc Surg. 2000;119(2):210-20.         [ Links ]

42. Schmid FX, Bielenberg K, Holmer S, Lehle K, Djavidani B, Prasser C, et al. Structural and biomolecular changes in aorta and pulmonary trunk of patients with aortic aneurysm and valve disease: implications for the Ross procedure. Eur J Cardiothorac Surg. 2004;25(5):748-53.         [ Links ]

43. Della Corte A, Quarto C, Bancone C, Castaldo C, Di Meglio F, Nurzynska D, et al. Spatiotemporal patterns of smooth muscle cell changes in ascending aortic dilatation with bicuspid and tricuspid aortic valve stenosis: focus on cell-matrix signaling. J Thorac Cardiovasc Surgery. 2008;135(1):8-18.         [ Links ]

44. Cotrufo M, Della Corte A, De Santo LS, Quarto C, De Feo M, Romano G, et al. Different patterns of extracellular matrix protein expression in the convexity and the concavity of the dilated aorta with bicuspid aortic valve: preliminary results. J Thorac Cardiovasc Surg. 2005;130(2):504-11.         [ Links ]

45. Sundt TM 3rd, Mora BN, Moon MR, Bailey MS, Pasque MK, Gay WA Jr. Options for repair of a bicuspid aortic valve and ascending aortic aneurysm. Ann Thorac Surg. 2000;69(5):1333-7.         [ Links ]

46. Yasuda H, Nakatani S, Stugaard M, Tsujita-Kuroda Y, Bando K, Kobayashi J, et al. Failure to prevent progressive dilation of ascending aorta by aortic valve replacement in patients with bicuspid aortic valve: comparison with tricuspid aortic valve. Circulation. 2003;108(Suppl 1):II291-4.         [ Links ]

47. Russo CF, Mazzetti S, Garatti A, Ribera E, Milazzo A, Bruschi G, et al. Aortic complications after bicuspid aortic valve replacement: long-term results. Ann Thorac Surg. 2002;74(5):S1773-6.         [ Links ]

48. Borger MA, Preston M, Ivanov J, Fedak PW, Davierwala P, Armstrong S, et al. Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease? J Thorac Cardiovasc Surg. 2004;128(5):677-83.         [ Links ]

49. Brown JW, Ruzmetov M, Rodefeld MD, Mahomed Y, Turrentine MW. Incidence of and risk factors for pulmonary autograft dilation after Ross aortic valve replacement. Ann Thorac Surg. 2007;83(5):1781-7.         [ Links ]

50. Davies RR, Kaple RK, Mandapati D, Gallo A, Botta DM Jr, Elefteriades JA, et al. Natural history of ascending aorta aneurysms in the setting of an unreplaced bicuspid aortic valve. Ann Thorac Surg. 2007;83(4):1338-44.         [ Links ]

51. Etz CD, Homann TM, Silovitz D, Spielvogel D, Bodian CA, Luehr M, et al. Long-term survival after the Bentall procedure in 206 patients with bicuspid aortic valve. Ann Thorac Surg. 2007;84(4):1186-93.         [ Links ]

52. Girdauskas E, Kuntze T, Borger MA, Doenst T, Mochalski M, Walther T. Long-term prognosis of type A aortic dissection in non-Marfan patients with histologic pattern of cystic medial necrosis. Ann Thorac Surg. 2008;85(3):972-7.         [ Links ]

53. Lad V, David TE, Vegas A. Mitral regurgitation due to myxomatous degeneration combined with bicuspid aortic valve disease is often due to prolapse of the anterior leaflet of the mitral valve. Ann Thorac Surg. 2009;87(1):79-82.         [ Links ]

 

 

Correspondence address:
Mauro Paes Leme
Av. Marechal Câmara 160, Sala 521 - Centro
Rio de Janeiro, RJ, Brazil - CEP 20020-080
E-mail: mpaesleme@oi.com.br

Article received on October 14th, 2008
Article accepted on April 6th, 2009

 

 

This study was carried out at the Surgery Department, Medical School of the Federal University of Rio de Janeiro, Clementino Fraga Filho University Hospital - Rio de Janeiro, RJ, Brazil.

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License